Chemistry, Manufacturing and Controls (CMC): are all stages of the drug development life cycle, after drug discovery. During preclinical drug development, the proper analytical methods are validated to monitor the product. Stability testing may be initiated, the physicochemical properties of the product are determined, raw materials are chosen and tested. When the drug development process moves into the clinical stage, further analytical method validation is required, and additional characterization of the drug product is needed.